sur Viromed Medical AG (isin : DE000A3MQR65)
Viromed Medical AG Announces Changes to Management Board
Viromed Medical AG has announced a significant change to its Management Board. The Supervisory Board has appointed Christian Strauch as a new member, effective immediately. Strauch, with over two decades of experience in the healthcare sector, will serve until October 31, 2029. His expertise lies in building and scaling companies, which aligns with Viromed's strategic goals.
Additionally, Uwe Perbandt, the company's founder, will step down from his position on the Management Board for personal reasons. Perbandt's resignation will be effective from December 31, 2026. This transition marks a new phase for Viromed, as it balances experienced leadership with its ongoing growth strategy.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Viromed Medical AG